Results 251 to 260 of about 1,181,357 (307)

Discharge health education needs and experiences of patients with skeletal-related events from bone metastases: A qualitative study. [PDF]

PLoS One
Shan J, Wang S, Ding F, Liang J, Wang J, Wang D.   +5 more
europepmc   +1 more source

Efficacy of Stereotactic Body Radiotherapy in Osteosarcoma Bone Metastases. [PDF]

J Pediatr Hematol Oncol
Sosa GA, Gannon DM, Luo G, Hills T, Lawrenz J, Borinstein SC, Gaines D, Whitaker R, Shinohara E, Kirschner A, Luo LY.   +10 more
europepmc   +1 more source

Machine learning decision tree models for multiclass classification of prognosis in patient undergoing palliative radiotherapy for bone metastases. [PDF]

J Appl Clin Med Phys
Cilla S, Rossi R, Habberstad R, Klepstad P, Agata MD, Kaasa S, Valenti V, Medici F, Donati CM, Maltoni M, Morganti AG.   +10 more
europepmc   +1 more source

Multidisciplinary approach to bone metastases: a single center experience in a tertiary cancer center. [PDF]

Support Care Cancer
Pittarello C, Brunello A, Lamberti E, Zovato S, Formaglio F, Galuppo S, Krengli M, Nena U, Angelini A, Ruggieri P, Pozza V, Pintacuda G, Pittaro A, Aldegheri V, Ballestrin M, Roma A, Lonardi S, Guarneri V, Falci C, Maruzzo M.   +19 more
europepmc   +1 more source

Bone metastases

Nature Reviews Disease Primers, 2020
Bone is the most frequent site for metastasis for many cancers, notably for tumours originating in the breast and the prostate. Tumour cells can escape from the primary tumour site and colonize the bone microenvironment. Within the bone, these disseminated tumour cells, as well as those arising in the context of multiple myeloma, may assume a state of ...
Marie Fallon, Edward Chow, Luis Costa
exaly   +7 more sources

Some of the next articles are maybe not open access.

Related searches:

Epidemiology of bone metastases

Bone, 2022
This study evaluated the incidence of de novo bone metastasis across all primary cancer sites and their impact on survival by primary cancer site, age, race, and sex.Our objectives were (I) characterize the epidemiology of de novo bone metastasis with respect to patient demographics, (II) characterize the incidence by primary site, age, and sex (2010 ...
Ryan, Casey, Stoltzfus, Kelsey C., Horn, Samantha, Chen, Hanbo, Louie, Alexander V., Lehrer, Eric J., Trifiletti, Daniel M., Fox, Edward J., Abraham, John A., Zaorsky, Nicholas G.   +9 more
openaire   +3 more sources

Radiotherapy of bone metastases

Cancer/Radiothérapie, 2022
We present the update of the recommendations of the French society of oncological radiotherapy on bone metastases. This is a common treatment in the management of patients with cancer. It is a relatively simple treatment with proven efficacy in reducing pain or managing spinal cord compression. More complex treatments by stereotaxis can be proposed for
S, Thureau, S, Supiot, E, Jouglar, M, Rogé, L, Lebret, A, Hadj Henni, G, Beldjoudi, J-L, Lagrange, J-C, Faivre   +8 more
openaire   +2 more sources

Radiopharmaceuticals for Bone Metastases

Seminars in Radiation Oncology, 2021
As a single organ distributed diffusely throughout the body, bones represent both a unique challenge and unique opportunity for the treatment of symptomatic metastatic disease. While the multifocality of bone metastases often prevents effective complete treatment with focal radiotherapy, the similar pathophysiology of these diffuse sites of disease ...
Andrew W, Smith, Benjamin A, Greenberger, Robert B, Den, Richard G, Stock   +3 more
openaire   +2 more sources

Bone Metastases

The Cancer Journal
Abstract Bone metastases occur frequently in common malignancies such as breast and prostate cancer. They are responsible for considerable morbidity and skeletal-related events. Fortunately, there are now several systemic, focal, and targeted therapies that can improve quality and length of life, including radionuclide therapies.
Gary J R, Cook, Matthew P, Thorpe
openaire   +3 more sources